Peps
What is P21?
P21 is a research-market label that needs sequence confirmation. The selected paper studied the CNTF-derived candidate P021; it is presented as related research rather than proof that every product labeled P21 has that identity.
Biological role or research focus
CNTF-derived candidate and P021 research context.
P021 evidence is related candidate evidence until the P21 preparation’s identity is verified. Animal cognition measures also do not establish a human benefit.
Role reference: Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. · 2014 ↗
Names you may encounter
Peptide 21
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- Ambiguous research label; exact sequence requires confirmation
- Research focus
- CNTF-derived candidate and P021 research context
- Featured evidence
- Related candidate · Animal study
- Source check
- October 4, 2026
Source: Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. · 2014 ↗
Biology & proposed mechanism
The P021 study investigated neurotrophic, neurogenesis, and synaptic measures. These candidate-specific observations should not be assigned to an unidentified peptide.
Source: Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. · 2014 ↗
Research context & identity
P21 also appears in unrelated biological terminology. A catalog name alone is insufficient to establish a CNTF-derived sequence or match the published P021 compound.
Source: Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. · 2014 ↗
What does the evidence show?
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Related candidate · Animal study · 2014
P021 in aged rats
What did this publication test, and what did it find?
- Population / model
- Aged Fischer rats, approximately 22–24 months old.
- Study design
- Oral P021 intervention with learning, memory, and brain-marker measurements.
- Main finding
- The report described improved learning and memory measures with changes in BDNF, neurogenesis, and synaptic markers in aged rats.
- Limits & context
- P021 evidence is related candidate evidence until the P21 preparation’s identity is verified. Animal cognition measures also do not establish a human benefit.
Source: Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. · 2014 ↗
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Further reading · 0 additional publication links
Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.
The P21 market label does not establish a sequence. Searches also return unrelated p21 biology. No further records are assigned until candidate identity is verified; the existing P021 note remains related-candidate evidence.
Repeat this PubMed search ↗New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Safety & precautions
Safety & what remains unknown
Unresolved sequence identity prevents assigning a unique structure or a candidate-specific safety profile.
Source: Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. · 2014 ↗
Evidence boundaries
P021 evidence is related candidate evidence until the P21 preparation’s identity is verified. Animal cognition measures also do not establish a human benefit.
Source: Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. · 2014 ↗
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
What are people discussing?
No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.
Watch the source discussions
6 matching video records · 3 with captions indexed.
Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.
Trevor Kruder
Episode 15: Peptides Explained: Sourcing, Quality & Women’s Health | Ginger Lichlyter ↗
Captions indexed · Automatic matches need review
Trevor Kruder
Episode 16: The Truth About Peptides: Testing, Manufacturing, Safety & the Future ↗
Captions indexed · Automatic matches need review
Trevor Kruder
Episode 17: Klotho & FLGR242 Explained: The Science Behind the Next Generation of Peptides ↗
Captions indexed · Automatic matches need review
Biohackingturkey
Beyni Gençleştiren Mucize: P21 Peptid Nedir? ↗
Title match · Captions not indexed
Biohackingturkey
P21 Peptidi: Hücrelerin Sessiz Kalkanı! 🛡️ ↗
Title match · Captions not indexed
Trevor Kruder
P21 and Dihexa Are Way Better Than You Think ↗
Title match · Captions not indexed
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
P-21 (5 mg)
American Peptides · Vendor-labeled research use only
$120.00
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.
Questions worth asking
- Is every P21 product confirmed to be the paper’s P021?
- What material, population, and route were actually studied?
- P021 evidence is related candidate evidence until the P21 preparation’s identity is verified. Animal cognition measures also do not establish a human benefit.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Is every P21 product confirmed to be the paper’s P021?
No. A sequence and modification specification are needed. This page keeps the published P021 candidate and an unverified P21 label distinct.
Source: Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. · 2014 ↗
Does the publication verify a supplier’s product?
No. The tested material and a commercial listing need separate identity and batch checks. A research-use disclaimer does not establish clinical suitability.
Source: Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. · 2014 ↗
References & editorial record
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.